[Continuous treatment with trimethoprim-sulfamethoxypyrazine of immunocompromised patients].
D000361:Agammaglobulinemia / Q000188:drug therapy*; D001424:Bacterial Infections / Q000517:prevention & control; D002675:Child, Preschool; D004338:Drug Combinations; D006105:Granulomatous Disease, Chronic / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D012189:Retrospective Studies; D013415:Sulfalene / Q000627:therapeutic use*; D013424:Sulfanilamides / Q000627:therapeutic use*; D014295:Trimethoprim / Q000627:therapeutic use*
D004338:Drug Combinations; D013424:Sulfanilamides; D014295:Trimethoprim; D013415:Sulfalene
Tratamiento continuo con trimetroprim-sulfametopirazina en pacientes inmunodeficientes.